Showing 1 - 17 results of 17 for search 'Anders Sundin', query time: 0.07s
Refine Results
-
1
-
2
Evaluation of block-sequential regularized expectation maximization reconstruction of 68Ga-DOTATOC, 18F-fluoride, and 11C-acetate whole-body examinations acquired on a digital time... by Elin Lindström, Lars Lindsjö, Anders Sundin, Jens Sörensen, Mark Lubberink
Published 2020-06-01
Article -
3
-
4
Impact of administered amount of peptide on tumor dosimetry at the first cycle of peptide receptor radionuclide therapy (PRRT) in relation to total tumor somatostatin receptor expr... by Ulrika Jahn, Ulrike Garske-Román, Mattias Sandström, Mark Lubberink, Anders Sundin
Published 2023-05-01
Article -
5
-
6
-
7
-
8
Receptor depletion and recovery in small-intestinal neuroendocrine tumors and normal tissues after administration of a single intravenous dose of octreotide measured by 68Ga-DOTATO... by Ulrika Jahn, Ezgi Ilan, Irina Velikyan, Katarzyna Fröss-Baron, Mark Lubberink, Anders Sundin
Published 2021-11-01
Article -
9
Peptide Receptor Radionuclide Therapy (PRRT) with <sup>177</sup>Lu-DOTATATE; Differences in Tumor Dosimetry, Vascularity and Lesion Metrics in Pancreatic and Small Intestinal Neuro... by Ulrika Jahn, Ezgi Ilan, Mattias Sandström, Mark Lubberink, Ulrike Garske-Román, Anders Sundin
Published 2021-02-01
Article -
10
-
11
PET-Guided Surgery — High Correlation between Positron Emission Tomography with 11C-5-Hydroxytryptophane (5-HTP) and Surgical Findings in Abdominal Neuroendocrine Tumours by Barbro Eriksson, Per Hellman, Göran Åkerström, Håkan Örlefors, Anders Sundin, Britt Skogseid, Kjell Öberg
Published 2012-02-01
Article -
12
-
13
Lessons on Tumour Response: Imaging during Therapy with 177Lu-DOTA-octreotate. A Case Report on a Patient with a Large Volume of Poorly Differentiated Neuroendocrine Carcinoma by Ulrike Garske, Mattias Sandström, Silvia Johansson, Dan Granberg, Hans Lundqvist, Mark Lubberink, Anders Sundin, Barbro Eriksson
Published 2012-01-01
Article -
14
Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with <sup>177</sup>Lu-DOTATATE by Achyut Ram Vyakaranam, Joakim Crona, Olov Norlén, Dan Granberg, Ulrike Garske-Román, Mattias Sandström, Katarzyna Fröss-Baron, Espen Thiis-Evensen, Per Hellman, Anders Sundin
Published 2019-06-01
Article -
15
Quality of Life in the First Year of Follow-Up in a Randomized Multicenter Trial Assessing the Role of Imaging after Radical Surgery of Stage IIB-C and III Cutaneous Melanoma (TRIM... by Ylva Naeser, Hildur Helgadottir, Johan Hansson, Christian Ingvar, Nils O. Elander, Petra Flygare, Cecilia Nilsson, Frida Jakobsson, Antonios Valachis, Dimitrios Papantoniou, Agneta Nordin Danfors, Hemming Johansson, Anders Sundin, Yvonne Brandberg, Gustav J. Ullenhag
Published 2022-02-01
Article -
16
TRIM study protocol - a prospective randomized multicenter Trial to assess the Role of Imaging during follow-up after radical surgery of stage IIB-C and III cutaneous malignant Mel... by Ylva Naeser, Hildur Helgadottir, Yvonne Brandberg, Johan Hansson, Roger Olofsson Bagge, Nils O. Elander, Christian Ingvar, Karolin Isaksson, Petra Flygare, Cecilia Nilsson, Frida Jakobsson, Olga del Val Munoz, Antonis Valachis, Malin Jansson, Charlotte Sparring, Lars Ohlsson, Ulf Dyrke, Dimitrios Papantoniou, Anders Sundin, Gustav J. Ullenhag
Published 2020-12-01
Article -
17
A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management by Kjell Oberg, Eric Krenning, Anders Sundin, Lisa Bodei, Mark Kidd, Margot Tesselaar, Valentina Ambrosini, Richard P Baum, Matthew Kulke, Marianne Pavel, Jaroslaw Cwikla, Ignat Drozdov, Massimo Falconi, Nicola Fazio, Andrea Frilling, Robert Jensen, Klaus Koopmans, Tiny Korse, Dik Kwekkeboom, Helmut Maecke, Giovanni Paganelli, Ramon Salazar, Stefano Severi, Jonathan Strosberg, Vikas Prasad, Aldo Scarpa, Ashley Grossman, Annemeik Walenkamp, Mauro Cives, Irene Virgolini, Andreas Kjaer, Irvin M Modlin
Published 2016-09-01
Article